Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 December 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 193 pages)

 

Export 70 results:
Author [ Title(Asc)] Type Year
Filters: Author is Leufkens, H. G.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
U
T. P. van Staa, Leufkens, H. G., and Cooper, C., Utility of medical and drug history in fracture risk prediction among men and women, Bone, vol. 31, pp. 508-14, 2002.
H. J. de Jong, Klungel, O. H., van Dijk, L., Vandebriel, R. J., Leufkens, H. G., van der Laan, J. W., Tervaert, J. W. Cohen, and Van Loveren, H., Use of statins is associated with an increased risk of rheumatoid arthritis, Ann Rheum Dis, vol. 71, pp. 648-54, 2012.
P. C. Souverein, Berard, A., van Staa, T. P., Cooper, C., Egberts, A. C., Leufkens, H. G., and Walker, B. R., Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study, Heart, vol. 90, pp. 859-65, 2004.
T. P. van Staa, Leufkens, H. G., Abenhaim, L., Begaud, B., Zhang, B., and Cooper, C., Use of oral corticosteroids in the United Kingdom, Qjm, vol. 93, pp. 105-11, 2000.
T. P. van Staa, Leufkens, H. G., Abenhaim, L., Zhang, B., and Cooper, C., Use of oral corticosteroids and risk of fractures, J Bone Miner Res, vol. 15, pp. 993-1000, 2000.
T. P. van Staa, Leufkens, H. G., and Cooper, C., Use of nonsteroidal anti-inflammatory drugs and risk of fractures, Bone, vol. 27, pp. 563-8, 2000.
T. P. van Staa, Cooper, C., Leufkens, H. G., Lammers, J. W., and Suissa, S., The use of inhaled corticosteroids in the United Kingdom and the Netherlands, Respir Med, vol. 97, pp. 578-85, 2003.
T. P. van Staa, Leufkens, H. G., and Cooper, C., Use of inhaled corticosteroids and risk of fractures, J Bone Miner Res, vol. 16, pp. 581-8, 2001.
L. M. Knapen, van Dalem, J., Keulemans, Y. C., van Erp, N. P., Bazelier, M. T., De Bruin, M. L., Leufkens, H. G., Croes, S., Neef, C., de Vries, F., and Driessen, J. H., Use of incretin agents and risk of pancreatic cancer: a population-based cohort study, Diabetes Obes Metab, vol. 18, pp. 258-65, 2016.
L. M. Knapen, de Jong, R. G., Driessen, J. H., Keulemans, Y. C., van Erp, N. P., De Bruin, M. L., Leufkens, H. G., Croes, S., and de Vries, F., Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study, Diabetes Obes Metab, vol. 19, pp. 401-411, 2017.
J. H. Driessen, van Onzenoort, H. A., Henry, R. M., Lalmohamed, A., van den Bergh, J. P., Neef, C., Leufkens, H. G., and de Vries, F., Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture, Bone, vol. 68, pp. 124-30, 2014.
F. de Vries, Souverein, P. C., Cooper, C., Leufkens, H. G., and van Staa, T. P., Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands, Calcif Tissue Int, vol. 80, pp. 69-75, 2007.
P. C. Souverein, van Staa, T. P., Egberts, A. C., De la Rosette, J. J., Cooper, C., and Leufkens, H. G., Use of alpha-blockers and the risk of hip/femur fractures, J Intern Med, vol. 254, pp. 548-54, 2003.
T. P. van Staa, Abenhaim, L., Cooper, C., Zhang, B., and Leufkens, H. G., The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results, Pharmacoepidemiol Drug Saf, vol. 9, pp. 359-66, 2000.
R
P. J. Peeters, Bazelier, M. T., Uitdehaag, B. M., Leufkens, H. G., De Bruin, M. L., and de Vries, F., The risk of venous thromboembolism in patients with multiple sclerosis: the Clinical Practice Research Datalink, J Thromb Haemost, vol. 12, pp. 444-51, 2014.
D. Gibson-Smith, Klop, C., Elders, P. J., Welsing, P. M., van Schoor, N., Leufkens, H. G., Harvey, N. C., van Staa, T. P., and de Vries, F., The risk of major and any (non-hip) fragility fracture after hip fracture in the United Kingdom: 2000-2010, Osteoporos Int, vol. 25, pp. 2555-63, 2014.
B. Spaetgens, de Vries, F., Driessen, J. H. M., Leufkens, H. G., Souverein, P. C., Boonen, A., van der Meer, J. W. M., and Joosten, L. A. B., Risk of infections in patients with gout: a population-based cohort study, Sci Rep, vol. 7, p. 1429, 2017.
J. van Dalem, Brouwers, M. C., Stehouwer, C. D., Krings, A., Leufkens, H. G., Driessen, J. H., de Vries, F., and Burden, A. M., Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study, Bmj, vol. 354, p. i3625, 2016.
M. T. Bazelier, de Vries, F., Vestergaard, P., Herings, R. M., Gallagher, A. M., Leufkens, H. G., and van Staa, T. P., Risk of fracture with thiazolidinediones: an individual patient data meta-analysis, Front Endocrinol (Lausanne), vol. 4, p. 11, 2013.
S. Pouwels, de Boer, A., Leufkens, H. G., Weber, W. E., Cooper, C., van Onzenoort, H. A., and de Vries, F., Risk of fracture in patients with muscular dystrophies, Osteoporos Int, vol. 25, pp. 509-18, 2014.
M. T. Bazelier, Van Staa, T., Uitdehaag, B. M., Cooper, C., Leufkens, H. G., Vestergaard, P., Bentzen, J., and de Vries, F., The risk of fracture in patients with multiple sclerosis: the UK general practice research database, J Bone Miner Res, vol. 26, pp. 2271-9, 2011.
S. Pouwels, de Boer, A., Leufkens, H. G., Weber, W. E., Cooper, C., van Staa, T. P., and de Vries, F., Risk of fracture in patients with Guillain-Barre syndrome, Osteoporos Int, vol. 25, pp. 1845-51, 2014.
S. Pouwels, de Boer, A., Leufkens, H. G., Weber, W. E., Cooper, C., and de Vries, F., Risk of fracture in patients with Charcot-Marie-Tooth disease, Muscle Nerve, vol. 50, pp. 919-24, 2014.
A. M. Gallagher, Smeeth, L., Seabroke, S., Leufkens, H. G., and van Staa, T. P., Risk of death and cardiovascular outcomes with thiazolidinediones: a study with the general practice research database and secondary care data, PLoS One, vol. 6, p. e28157, 2011.
P. J. Peeters, Bazelier, M. T., Leufkens, H. G., de Vries, F., and De Bruin, M. L., The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity, Diabetes Care, vol. 38, pp. 495-502, 2015.
M. T. Bazelier, Mueller-Schotte, S., Leufkens, H. G., Uitdehaag, B. M., Van Staa, T., and de Vries, F., Risk of cataract and glaucoma in patients with multiple sclerosis, Mult Scler, vol. 18, pp. 628-38, 2012.
K. B. Handoko, Souverein, P. C., van Staa, T. P., Meyboom, R. H., Leufkens, H. G., Egberts, T. C., and van den Bemt, P. M., Risk of aplastic anemia in patients using antiepileptic drugs, Epilepsia, vol. 47, pp. 1232-6, 2006.
J. P. Yska, van Roon, E. N., de Boer, A., Leufkens, H. G., Wilffert, B., de Heide, L. J., de Vries, F., and Lalmohamed, A., Remission of Type 2 Diabetes Mellitus in Patients After Different Types of Bariatric Surgery: A Population-Based Cohort Study in the United Kingdom, JAMA Surg, vol. 150, pp. 1126-33, 2015.
P
T. P. van Staa, Abenhaim, L., Cooper, C., Zhang, B., and Leufkens, H. G., Public health impact of adverse bone effects of oral corticosteroids, Br J Clin Pharmacol, vol. 51, pp. 601-7, 2001.
M. J. Willemen, Mantel-Teeuwisse, A. K., Straus, S. M., Leufkens, H. G., and Egberts, A. C., Psychiatric and cardiovascular comorbidities in patients with diabetes mellitus starting antiobesity drugs, Obesity (Silver Spring), vol. 16, pp. 2331-5, 2008.
C. Klop, de Vries, F., Bijlsma, J. W., Leufkens, H. G., and Welsing, P. M., Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density, Ann Rheum Dis, vol. 75, pp. 2095-2100, 2016.
A. Lalmohamed, Macgregor, A. J., de Vries, F., Leufkens, H. G., and van Staa, T. P., Patterns of risk of cancer in patients with metal-on-metal hip replacements versus other bearing surface types: a record linkage study between a prospective joint registry and general practice electronic health records in England, PLoS One, vol. 8, p. e65891, 2013.
H. A. van den Ham, Klungel, O. H., Leufkens, H. G., and van Staa, T. P., The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non-valvular atrial fibrillation, J Thromb Haemost, vol. 11, pp. 107-15, 2013.
[Page last reviewed 6 December 2019]